FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
Enanta Pharma (NASDAQ: ENTA) reported Q4 EPS of $0.29, $0.14 better than the analyst estimate of $0.15. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $16.44 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
... More
